FindTrial
Sign In

The duration of hormonal replacement therapy after hysteroscopic adhesiolysis: a randomized controlled trial

The duration of hormonal replacement therapy after hysteroscopic adhesiolysis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021459
Enrollment
Unknown
Registered
2019-02-22
Start date
2019-03-07
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman's syndrome

Interventions

Group 1:21 days Hormonal treatment
Group 2:28 days Hormonal treatment

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. AFS>= 5 in the hysteroscopic adhesiolysis; 2. Menstrual cycle <=28 days and with fluctuation within 7 days; 3. Aged 18-40 years.

Exclusion criteria

Exclusion criteria: 1. With contradiction of hormone treatment; 2. PCOS; 3. Previous hysteroscopic history.

Design outcomes

Primary

MeasureTime frame
AFS SCORE;—

Countries

China

Contacts

Public ContactYue Wang

Women's Hospital, School of Medicine, Zhejiang University

misswangyue@163.com+86 13588433305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026